601607 上海医药
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)5.8175.5589.65010.75510.335
总资产报酬率 ROA (%)1.8611.8383.1073.2593.142
投入资产回报率 ROIC (%)3.1843.1465.5105.8705.317

边际利润分析
销售毛利率 (%)11.05612.03613.14213.22513.928
营业利润率 (%)3.1812.9463.8863.8023.744
息税前利润/营业总收入 (%)3.7183.2814.3634.3504.385
净利润/营业总收入 (%)2.3961.9853.0142.9072.921

收益指标分析
经营活动净收益/利润总额(%)93.242103.28880.31175.92088.486
价值变动净收益/利润总额(%)7.3104.7728.53619.71315.232
营业外收支净额/利润总额(%)-0.367-8.689-2.342-0.757-0.124

偿债能力分析
流动比率 (X)1.3421.3271.3511.2691.220
速动比率 (X)1.0521.0281.0390.9730.947
资产负债率 (%)62.83362.10560.63263.86063.307
带息债务/全部投入资本 (%)43.02242.10339.01138.29940.469
股东权益/带息债务 (%)126.439130.853149.257145.253132.160
股东权益/负债合计 (%)50.40852.05255.82447.29348.022
利息保障倍数 (X)6.7825.7487.7087.5396.789

营运能力分析
应收账款周转天数 (天)100.46896.60196.88892.45393.875
存货周转天数 (天)53.72455.88254.99749.20253.359